Neuronetics (STIM) Cost of Revenue (2017 - 2026)

Neuronetics (STIM) has 10 years of Cost of Revenue data on file, last reported at $18.3 million in Q1 2026.

• Quarterly Cost of Revenue rose 12.71% year-over-year to $18.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $62.1 million (up 7.93% YoY) and the FY2025 annual result came in at $47.5 million, up 4.0% from the prior year.
• Cost of Revenue grew to $18.3 million in Q1 2026 per STIM's latest filing, from $11.7 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $38.9 million in Q4 2022 and bottomed at -$16.0 million in Q4 2023.
• The 5-year median for Cost of Revenue is $11.7 million (2025), against an average of $11.0 million.
• The widest annual swing landed in 2022, when Cost of Revenue soared 346.48%; it then tumbled 141.04% in 2023.
• Tracing STIM's Cost of Revenue over 5 years: stood at $38.9 million in 2022, then plunged by 141.04% to -$16.0 million in 2023, then surged by 303.66% to $32.5 million in 2024, then sank by 63.87% to $11.7 million in 2025, then soared by 55.84% to $18.3 million in 2026.
• Per Business Quant, the three latest STIM Cost of Revenue figures stand at $18.3 million (Q1 2026), $11.7 million (Q4 2025), and $20.2 million (Q3 2025).

Peer Comparison